In March 2017 World Rugby has reported an anti-doping rule violation against the rugby player Adrian Gabriel Chiper after his sample tested positive for the prohibited substance 19-norandrosterone (Nandrolone). After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the World Rugby Judicial Committee. The Athlete admitted the violation, denied the intentional use and was unaware that there was anti-doping information on the internet neither that steroids were prohibited. He stated that he had purchased the substance as medication on the internet as treatment for his knee injury. He acknowledged that he didn’t report his injury to the team officials and failed to mention his medication on the Doping Control Form. He only discussed his medication with his team doctor after de sample collection. World Rugby contended that the Athlete failed to demonstrate that the violation was not intentional nor how the substance entered his system. It requested the Committee for the imposition of a 4 year period of ineligibility. On the balance of probabilities, the Judicial Committee is skeptical about the Athlete’s statement. The Committee holds that to self-diagnose and to self-treat a knee injury in the sport of rugby, based on advice from Google, is difficult to understand. The Committee finds it difficult to accept the Athlete’s version how the prohibited substance entered his system. While not absolutely essential to proving that the violation was unintentional, any question about the source of the prohibited substance severely undercuts the Athlete’s case on this point. Therefore the World Rugby Judicial Committee decides on 20 August 2018 to impose a 4 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 10 November 2017.
Used filter(s): 312 items found
- Remove all filters
- Search: Baseball
Anti-doping Policy, Therapeutic Use Exemption and Medication Use in Athletes with Asthma : A Narrative Review and Critical Appraisal of Current Regulations / Hayden Allen, Susan H. Backhouse, James H. Hull, Oliver J. Price . - (Sports Medicine (2019) 18 March; p. 1-10). - PMID: 30887312. - DOI: 10.1007/s40279-019-01075-z ___________________________________________________ Abstract Asthma is prevalent in athletes and when untreated can impact both respiratory health and sports performance. Pharmacological inhaler therapy currently forms the mainstay of treatment; however, for elite athletes competing under the constraints of the World Anti-Doping Code (Code), a number of established therapies are prohibited both in and/or out of competition and/or have a maximum permitted dose. The recent release of medical information detailing inhaler therapy in high-profile athletes has brought the legitimacy and utilisation of asthma medication in this setting into sharp focus. This narrative review critically appraises recent changes to anti-doping policy and the Code in the context of asthma management, evaluates the impact of asthma medication use on sports performance and employs a theory of behaviour to examine perceived determinants and barriers to athletes adhering to the anti-doping rules of sport when applied to asthma.
Report of the Independent Observers XVIII Asian Games Jakarta Palembang 2018 / Independent Observer Team. - Montreal : World Anti-Doping Agency (WADA), 2019
Impact of anti-doping education and doping control experience on anti-doping knowledge in Japanese university athletes: a cross-sectional study
Impact of anti-doping education and doping control experience on anti-doping knowledge in Japanese university athletes: a cross-sectional study / Yuka Murofushi, Yujiro Kawata, Akari Kamimura, Masataka Hirosawa, Nobuto Shibata. - (Substance abuse treatment, prevention, and policy 13 (2018) 44 (5 Dec); p. 1-15). - PMID: 30518383. - PMCID: PMC6280366. - DOI: 10.1186/s13011-018-0178-x _________________________________________________ Abstract: BACKGROUND: This study was conducted to elucidate the anti-doping (AD) education, doping control experience, and AD knowledge according to the World Anti-doping Code (Code) of Japanese university athletes. METHODS: We collected data from 514 male athletes (Mage = 19.53 years, SD = 1.13) and 629 female athletes (Mage = 20.99 years, SD = 1.07). We asked them about their experience undergoing doping control and the AD education they had received. Then, we assessed their AD knowledge using the World Anti-Doping Agency's Athlete Learning Program about Health and AD (ALPHA) test. RESULTS: The results showed that 2.54% of the participants had undergone doping control. Further, 30.10% received AD education at least once, and 20.82% received AD education more than once. When comparing the ALPHA scores of athletes with/without doping test experience, we observed no significant difference. However, the ALPHA scores of athletes with/without AD education were significantly different; specifically, athletes who received AD education more than once had significantly higher ALPHA scores than non-educated athletes. CONCLUSION: These results revealed that doping control experience was not related to AD knowledge and that AD education was associated with AD knowledge, suggesting that athletes who receive AD education more than once have more accurate AD knowledge than less educated athletes on this topic. The importance of AD education in promoting understanding of AD according to the Code in sports is highlighted in this study.
iNADO Update (2018) 9 (23 November) Institute of National Anti-Doping Organisations (iNADO) ____________________________________________________ Contents: - 2019 iNADO Workshop (March 12, Lausanne) - Report on the WADA Foundation Board and associated meetings, Baku, November 13-15 2018. CEO Graeme Steel - The Role of NADOs – Comment from the CEO - NADOs give Feedback to the 2nd Draft of the Int. Standard for Education (ISE) - Ideas how to implement the ISE using a Guidelines Document - Spanish Anti-Doping Agency launches Education Module in Latin America - Annual Larry D. Bowers Award for Excellence in Anti-Doping Science - New NSF Certified for Sport® Certification Mark - Leeds Beckett University: the Global Landscape of Whistleblowing Platforms - Improved Search Function at the Anti-Doping Knowledge Center - Vacancies at WADA - New at the Anti-Doping Knowledge Centre
Related case: ISR 2017 KNBSB Decision Disciplinary Committee 2017013 T November 30, 2017 On 30 November 2017 the ISR-KNBSB Disciplinary Committee decided to impose a 2 year period of ineligibility on the Person after his sample tested positive for the prohibited substance Cannabis. Here the Person failed to file a statement in his defence nor did he request to be heard. During the disciplinary proceedings the Person made in June 2017 a TUE application for the use of Cannabis which was refused by the Dutch TUE Commission on 18 July 2017. When sanctioned for 2 years on 30 November 2017 the Person appealed in December 2017 this KNBSB decision. Further in January 2017 the Person made a second application with the TUE Commission for the medical use of Cannabis. In support of his appelication the Person filed medical information, a copy of his first TUE application from June 2017 and a medical certificate from his doctor. However the Anti-Doping Authority Netherlands (Dopingautoriteit) reported in January 2018 that the signature of the Person's doctor in the first TUE application was different from the signature used in the second TUE application. On being asked the doctor in question confirmed to the Dopingautoriteit that the medical certificate and signature in the second TUE application were not rendered by him. Hereafter the Person resigned in January 2018 his KNBSB membership and in March 2018 he withdrew his appeal. The Dopingautoriteit reported in April 2018 a second anti-doping rule violation against the Person for Tampering due to his falsification of a medical certificate. After notification the Person failed again to file a statement in his defence nor did he request to be heard for the ISR-KNBSB Disciplinary Committee. The case was settled based on the filed submissions. In spite of the Person’s membership resignation the ISR-KNBSB Disciplinary Committee holds that under the Rules the Person was still a member of the KNBSB until the end of the year 2018 and accordingly still submitted to the Anti-Doping Rules. The Disciplinary Committee accepts the filed evidence in this case against the Person and concludes that he committed a second anti-doping rule violation as a result of writing a false medical certificate and falsification of the doctor’s signature. Since the Person didn't file a statement in his defence the Committee holds that the Person failed to establish grounds for a reduced sanction. Therefore the ISR-KNBSB Disciplinary Committee decides on 8 August 2018 to impose a 8 year period of ineligibility on the Person starting on the date of the decision. Fees and expenses for this committee shall be borne by the Person.
Related case: ISR 2018 KNBSB Decision Disciplinary Committee 2018003 T August 8, 2018 In July 2017 the Royal Dutch Baseball and Softball Federation (KNBSB) has reported an anti-doping rule violation against the Person after his sample tested positive for the prohibited substance Cannabis in a concentration above the WADA threshold (473 ng/mL). After notification the Person failed to file a statement in his defence nor did he request to be heard for the ISR-KNBSB Disciplinary Committee. The case was settled based on the filed submissions. The Disciplinary Committee concludes that the evidence establish that the Person committed an anti-doping rule violation. Without evidence to the contrary the Committee finds that the violation was not intentional as ground for a reduced sanction. Since the Person didn't file a statement in his defence the Committee holds that the Person failed to establish how the substance entered his system. Without further grounds for a reduced sanction the ISR-KNBSB Disciplinary Committee decides on 30 November 2017 to impose a 2 year period of ineligibility on the Person starting on the date of the decision. Fees and expenses for this committee shall be borne by the Person.
2017 Anti-Doping Testing Figures / World Anti-Doping Agency (WADA). - Montreal : WADA, 2018 Contents: - Executive Summary - pp. 2-9 (7 pages) - Laboratory Report -– pp. 10-36 (26 pages) - Sport Report - pp. 37-158 (121 pages) - Testing Authority Report - pp. 159-298 (139 pages) - ABP Report-Blood Analysis - pp. 299-336 (37 pages)